Phreesia (PHR)
(Real Time Quote from BATS)
$23.50 USD
-0.26 (-1.09%)
Updated Sep 20, 2024 01:46 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
PHR 23.50 -0.26(-1.09%)
Will PHR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PHR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PHR
Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest?
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
PHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates
Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Augmedix, Inc. (AUGX) Reports Q2 Loss, Lags Revenue Estimates
Other News for PHR
Phreesia Inc (PHR) Shares Gap Down to $23.03 on Sep 20
New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence
Phreesia Inc (PHR) Stock Price Down 3.28% on Sep 16
Phreesia (PHR) Improves Healthcare Outcomes and Expects Growing Clientele